Diligence memo · auto-generated · as of July 2, 2026
San Andres Genetics
San Andres Genetics looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
San Andres Genetics operates in Other Technology, based in LOS ANGELES.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
San Andres Genetics has raised $188M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $180M on 2022-03-08.
Most recent recorded round closed around 2022-03-08.
Valuation (modeled)modeled
Provath models San Andres Genetics at approximately $3.7B (range $1000M–$6.7B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.77× the median modeled value of Series D+ Other Technology companies in 2022–2024 (75 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 13 months.
Last raise 4.3 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 24.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 98% of Other Technology peers (21302 compared).
Modeled value ranks above 99% of those peers.
Closest niche peers: Memphis Meats, Inc., Edgio, Inc., Siprocal, Inc, PacketFabric, Inc., Guess & Co. Corp.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.